Ceramic Nano-Vehicles for Controlled Delivery of Functional Bio-Molecules by Chakraborty, Manjusha
Abstract

Ceramic Nano-Vehicles for Controlled Delivery of Functional Bio-Molecules

Drug delivery via nanoparticles allows efficient delivery of the active agents to reduce the side effect of the drugs and thus, improve patient compliance. Although very less number of FDA (Food and Drug Administration) approved nanoformulations are available commercially, they exhibit enormous potential in addressing the failures of conventional therapeutics, especially in cancer. Here, a nanoceramic anionic clay, layered double hydroxide (LDH) that are biodegradable (pH dependent), non cytotoxic and biocompatible in nature, has spurred a lot of interest and attention in recent years. They comprise a cationic bilayer, (general formula [M2+1–xM3+x(OH)2]x+(An–)x/n ·mH2O] [M2+= Mg, Zn, Ca, M3+=Al, Fe]), encapsulate various drugs including non steroidal, antiflammatory, anti cancerous etc. within its interlayer space and can be used directly for transport to the diseased cell. 
The present study focuses on the synthesis of Mg-Al, Zn-Al, Ca-Al LDHs and intercalation of methotrexate (MTX), an anionic anticancerous drug. The LDH-MTX nanohybrids (50-200 nm) were extensively characterized using XRD, FTIR, TG-DTA, TEM, FESEM, CHN and DLS techniques. The results indicated a specific orientation of the drug molecule, increased stability of the drug molecule, controlled release of the drug at physiological pH (7.4). Interestingly, the Mg-AlLDH-MTX formulation showed higher inhibition capacity against cancerous cell (Human Osteosarcoma: MG-63) proliferation (>20%) compared to the bare drug (MTX). In summary, the above novel drug delivery system exhibits a huge market potential that can replace the existing chemotherapeutic agents and revolutinize the entire drug delivery concept.



